WCG acquisition expands services to patient recruitment

By Melissa Fassbender contact

- Last updated on GMT

ThreeWire has screened more than 2 million patients in more than 25 countries. (Image: iStock/Kritchanut)
ThreeWire has screened more than 2 million patients in more than 25 countries. (Image: iStock/Kritchanut)

Related tags: Patient recruitment, Clinical trial

WIRB-Copernicus Group (WCG) has acquired the global patient recruitment, enrollment, and retention firm, ThreeWire.

"The ThreeWire approach to providing global clinical trial patient recruitment, enrollment, retention, and research site optimization services is a natural fit with WCG​," Mark Summers, ThreeWire CEO told Outsourcing-Pharma.com.

According to the company, it combines technology with “on-the-ground resources” to help investigators recruit and conduct clinical studies.

Additionally, ThreeWire has more than 300 clinical research professionals, called “Enrollment Assistants,” who work at study sites to close resource gaps where needed.

Other on-site recruitment services include patient chart review as a step to identify study candidates and conducting community outreach to patient groups and referral physicians.

The company’s US headquarters are Minneapolis with another base in Frankfurt, Germany.

"Together, WCG and ThreeWire accelerate study start-up for sponsors and contract research organizations (CROs), improve ROI on clinical trials, and accelerate patient access to innovative medicines,​" said Summers.  

"With the growth that ThreeWire has experienced both domestically and globally, it was time to find an organization with which they could continue to have scalable and innovative growth while ensuring their mission and values were aligned​," he added.

As part of the acquisition, terms of which were not disclosed, ThreeWire will continue to operate as an independent organization.

"There is no plan to “fully absorb” ThreeWire into WCG. WCG’s plan for ThreeWire is to support them to operate independently, while providing resources to help the company as it continues to expand, with access to capital, complementary clinical and regulatory expertise, and corporate support​," Summers explained.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more